Montelukast Sodium

• Montelukast Sodium is a leukotriene receptor antagonist used for the long-term management of asthma and allergic rhinitis.
• It works by blocking the action of leukotrienes, reducing inflammation and airway constriction.
• The medication is taken once daily, typically in the evening, and is available in various forms for different age groups.
• It is not intended for the immediate relief of acute asthma attacks.
• Potential side effects include headache and gastrointestinal issues, with rare but serious neuropsychiatric events requiring careful monitoring.

What is Montelukast Sodium and How It Works

Montelukast Sodium is a medication classified as a leukotriene receptor antagonist. It is primarily used to treat asthma and allergic rhinitis by targeting specific inflammatory pathways in the body. This compound is designed for long-term control and prevention of symptoms, rather than for immediate relief during acute episodes.

Understanding how montelukast sodium works in the body involves recognizing the role of leukotrienes. Leukotrienes are naturally occurring inflammatory chemicals released by the body, particularly in the lungs and nose, in response to allergens or irritants. These chemicals contribute to bronchoconstriction (narrowing of airways), increased mucus production, and inflammation, which are characteristic features of asthma and allergic rhinitis. Montelukast Sodium selectively binds to and blocks the action of leukotriene D4 receptors, thereby inhibiting the effects of leukotrienes. This action helps to reduce inflammation, relax the airways, and decrease mucus secretion, leading to improved breathing and reduced allergic symptoms.

Montelukast Sodium Uses and Dosage for Asthma

Montelukast Sodium is primarily used for the long-term treatment and prevention of asthma symptoms in adults and children aged 12 months and older. It is also approved for the relief of symptoms of seasonal allergic rhinitis in adults and children aged 2 years and older, and perennial allergic rhinitis in adults and children aged 6 months and older. It is important to note that this medication is a maintenance therapy and should not be used to treat acute asthma attacks, for which a fast-acting bronchodilator is typically required.

The montelukast sodium dosage for asthma varies by age group and is typically administered once daily in the evening. Adherence to the prescribed dosage is crucial for effective management of symptoms. Common dosages include:

• Adults and adolescents (15 years and older): 10 mg tablet once daily.
• Children (6 to 14 years): 5 mg chewable tablet once daily.
• Children (2 to 5 years): 4 mg chewable tablet or 4 mg oral granules once daily.
• Children (12 to 23 months for asthma, 6 to 23 months for perennial allergic rhinitis): 4 mg oral granules once daily.

The granules can be mixed with soft food or breast milk/formula and should be consumed immediately. Consistent daily use, even when symptoms are absent, is vital for preventing asthma exacerbations and controlling allergic rhinitis.

Montelukast Sodium Side Effects and Warnings

While generally well-tolerated, montelukast sodium side effects and warnings are important considerations for patients and healthcare providers. Common side effects often include headache, abdominal pain, nausea, diarrhea, and upper respiratory infection. These are usually mild and may subside as the body adjusts to the medication.

More serious, though less common, side effects can occur. These include neuropsychiatric events such as agitation, aggression, anxiety, depression, disorientation, hallucinations, insomnia, irritability, restlessness, tremor, and, in rare cases, suicidal thoughts and behavior. Patients and caregivers should be vigilant for any changes in mood, behavior, or thoughts and report them to a healthcare professional immediately. Additionally, liver problems, though rare, have been reported, manifesting as symptoms like dark urine, persistent nausea/vomiting, or yellowing of the skin/eyes.

Important warnings associated with Montelukast Sodium include: it should not be used to treat acute asthma attacks; patients should continue to use their rescue inhalers as prescribed. It is also crucial not to abruptly stop taking other asthma medications unless advised by a doctor. Patients with phenylketonuria should be aware that chewable tablets contain aspartame. As with any medication, discussing all existing medical conditions and current medications with a healthcare provider is essential to ensure safe and effective treatment.